Nucleic acid vaccines are designed based on genetic sequences (DNA or mRNA) of a target antigen to be expressed to drive a host immune response. In response to the COVID-19 pandemic, mRNA and DNA vaccines based on the SARS-CoV-2 Spike antigen were developed. Surprisingly, head-to-head characterizations of the immune responses elicited by each vaccine type has not been performed to date.
View Article and Find Full Text PDF